MATIAS CLINICAL LABORATORY INC
NPI 1962546176, organization, Baldwin Park, CA, Clinical Medical Laboratory
- Listed on the Medicare revocation list since August 31, 2018.
- Medicaid still paid claims in 44 later months, $3,846,471 in total.
- Adjudicated (sentenced) per a Department of Justice release dated January 30, 2024.
Public list actions
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| CA Medicaid exclusion list ca medi-cal suspended & ineligible provider list (july 2026) | Exact NPI, name conflict (set aside) | Aug 31, 2018 | still open | 44 | Sep 2018 | Apr 2022 | $3.8M | $312K |
| Medicare revocation list 424.535(a)(4) false or misleading information and 424.535(a)(3) felonies and 424.535(a)(2) provider or supplier conduct (exclusion) | Exact NPI, name verified | Aug 31, 2018 | Nov 22, 2034 | 44 | Sep 2018 | Apr 2022 | $3.8M | $312K |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | MATIAS CLINICAL LABORATORY INC (also HEALTH CARE PROVIDERS LABORATORY INC) |
| Type | Organization |
| Status | Active |
| NPI issued | February 19, 2007, last updated August 7, 2020 |
| Practice location | 14411 PALMROSE STREET, Baldwin Park, CA 91706, 626-813-3800 |
| Authorized official | EMILIO VILLARBA (President) |
| Specialties | Clinical Medical Laboratory (291U00000X, primary) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $730K | 18% | $120 | $75 (top 5% from $185) | 88th percentile | |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | $673K | 17% | $64 | $33 (top 5% from $227) | 75th percentile | |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | $349K | 9% | $55 | $71 (top 5% from $112) | 31st percentile | |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | $279K | 7% | $52 | $74 (top 5% from $182) | 33rd percentile | |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | $258K | 7% | $41 | $48 (top 5% from $77) | 39th percentile | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $207K | 5% | $118 | $146 (top 5% from $318) | 38th percentile | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | $174K | 4% | $33 | $20 (top 5% from $39) | 92nd percentile | |
| 87486 | Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | $156K | 4% | $24 | $23 (top 5% from $56) | 52nd percentile |
In this area
399 providers in Los Angeles County, CA carry an indicator in the public record, with $125.8M at stake between them. The most common is part of a provider network, on 347 of them, followed by paid after a public list action on 36. 52 are tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | BURBANK PREFERRED PROVIDER MEDICAL GROUP, INC Burbank, CA, ranked 17 | $67K |
|
| 1 | GOLDEN STAR LABS LLC Los Angeles, CA, ranked 32 | $41.0M |
|
| 1 | HEALTHSMART PACIFIC INC Long Beach, CA, ranked 52 | $1.6M |
|
| 1 | LINDA WARREN-WATSON Lancaster, CA, ranked 71 | $828K |
|
| 1 | SOHRAB MOSHIRI Woodland Hills, CA, ranked 82 | $483K |
|
| 1 | QUALITY FAMILY HOSPICE CARE INC Tarzana, CA, ranked 92 | $375K |
|
| 1 | MARATHON HOSPICE CARE INC. North Hollywood, CA, ranked 95 | $368K |
|
| 1 | SOFT TOUCH HOSPICE, INC Glendale, CA, ranked 106 | $247K |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
Referral packet: MATIAS CLINICAL LABORATORY INC
Public records show NPI 1962546176, MATIAS CLINICAL LABORATORY INC, an organization laboratory in Baldwin Park, CA with a Medicaid home state of Missouri, was placed on the Medicare revocation list on August 31, 2018 under 424.535(A)(4), 424.535(A)(3) and 424.535(A)(2), with a re-enrollment bar running to November 22, 2034, and appears on the California Medi-Cal Suspended and Ineligible Provider List with the same action date. Medicaid records show $3,846,471 paid across 44 service months from September 2018 through April 2022, after that action date, which warrants a records request to confirm enrollment status, screening history and the basis for the later payments.
This referral candidate is a clinical laboratory organization in Baldwin Park, California that bills Medicaid with Missouri listed as its home state. Records show it was revoked from Medicare on August 31, 2018 on three grounds, including false or misleading information and felonies, with a bar on re-enrolling until November 22, 2034, and it also appears on the California Medi-Cal Suspended and Ineligible Provider List with the same date. Medicaid records show payments continued after that date, totaling $3,846,471 over 44 service months from September 2018 through April 2022, compared with $312,286 in the twelve months before. Its largest paid code is the high throughput COVID-19 test U0003 at $729,801 over 24 months, priced at $120 per patient-month against a typical $75, which is the 88th percentile among providers billing that code. A second nucleic acid detection code, 87798, accounts for $672,654 over 49 months at $64 per patient-month against a typical $33.
- 01NPI 1962546176 is registered to MATIAS CLINICAL LABORATORY INC, an organization in Baldwin Park, CA, with taxonomy 291U00000X and a Medicaid home state of MO. records 1
- 02The provider was revoked on 2018-08-31 under 424.535(A)(4) False Or Misleading Information, 424.535(A)(3) Felonies and 424.535(A)(2) Provider Or Supplier Conduct (Exclusion), with a re-enrollment bar to 2034-11-22. records 9
- 03After the Medicare revocation action of 2018-08-31, Medicaid paid $3,846,471 across 44 service months from 2018-09 to 2022-04, compared with $312,286 in the 12 months before. records 10
- 04After the California state exclusion action of 2018-08-31, tied to the California Medi-Cal Suspended and Ineligible Provider List, Medicaid paid $3,846,471 across 44 service months from 2018-09 to 2022-04. records 11
- 05The record is classified as evidence tier 1, documented action then payment, with detector D3 and dollars at risk of $3,846,471, described as the figure of the detector that set the tier and not a sum. records 8
- 06Code U0003, the high throughput SARS-CoV-2 nucleic acid detection test, was paid $729,801 over 24 months, 18 percent of this provider's Medicaid dollars, at $120 per patient-month, ranking at the 88th percentile of all providers billing this code against a typical $75. records 2
- 07Code 87798, detection test by nucleic acid for organism, amplified probe technique, was paid $672,654 over 49 months, 17 percent of this provider's Medicaid dollars, at $64 per patient-month, ranking at the 75th percentile against a typical $33. records 3
- 08Code 87502, detection test by nucleic acid for multiple types influenza virus, was paid $348,859 over 49 months, 9 percent of this provider's Medicaid dollars, at $55 per patient-month, ranking at the 31st percentile against a typical $71. records 4
- 09Code 87631, respiratory virus panel with 3 to 5 targets, was paid $279,418 over 31 months, 7 percent of this provider's Medicaid dollars, at $52 per patient-month, ranking at the 33rd percentile against a typical $74. records 5
- 10Code 87634, respiratory syncytial virus nucleic acid detection, was paid $258,473 over 48 months, 7 percent of this provider's Medicaid dollars, at $41 per patient-month, ranking at the 39th percentile against a typical $48. records 6
- 11Code G0483, definitive drug testing, was paid $206,715 over 25 months, 5 percent of this provider's Medicaid dollars, at $118 per patient-month, ranking at the 38th percentile against a typical $146. records 7
Request the full Medicaid enrollment file for NPI 1962546176, including the application, all revalidation and screening records, and any documentation of appeal, reinstatement or reversal of the Medicare revocation dated 2018-08-31 and of the California Medi-Cal Suspended and Ineligible listing. Confirm whether the provider appears in the termination database and whether denial or termination of enrollment was required under 42 CFR 455.416(c), and pull the monthly exclusion and NPPES screening logs required by 42 CFR 455.436 for the period September 2018 through April 2022 to establish when the state first matched this provider. Obtain the claim level detail behind the $3,846,471 paid across the 44 service months, with attention to the U0003 and 87798 lines and to whether claims were billed directly or through another billing entity, ordering provider or managed care plan. If the review supports a credible allegation of fraud, evaluate a full or partial payment suspension under 42 CFR 455.23(a) and make the referral to the Medicaid Fraud Control Unit required by 42 CFR 455.23(d), and document the specific 42 CFR 424.535(a) grounds cited in the Medicare action.
| program | code | what it is | paid | share | comparison |
|---|---|---|---|---|---|
| Medicaid | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $730K | 18% | 88th percentile of providers on this code ($120 per patient-month, typical $75) |
| Medicaid | 87798 | Detection test by nucleic acid for organism, amplified probe technique | $673K | 17% | 75th percentile of providers on this code ($64 per patient-month, typical $33) |
| Medicaid | 87502 | Detection test by nucleic acid for multiple types influenza virus | $349K | 9% | 31st percentile of providers on this code ($55 per patient-month, typical $71) |
| Medicaid | 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | $279K | 7% | 33rd percentile of providers on this code ($52 per patient-month, typical $74) |
| Medicaid | 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | $258K | 7% | 39th percentile of providers on this code ($41 per patient-month, typical $48) |
| Medicaid | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $207K | 5% | 38th percentile of providers on this code ($118 per patient-month, typical $146) |
- The Medicare revocation may have been appealed, stayed or reversed, or the provider may have been reinstated, and the extract may not reflect the current status.
- Payments after the action date can reflect claims for dates of service before the action, timely filing lags, adjustments, voids or recoupments already applied, so the paid amount may not equal net dollars retained.
- The dollars at risk figure of $3,846,471 is described as the figure of the detector that set the tier and not a sum, so it should not be treated as a computed overpayment.
- T-MSIS and exclusion list data carry reporting lag, and the California list citation references a July 2026 file, so effective dates and match logic must be verified against source records before conclusions are drawn.
- The provider is a laboratory organization whose claims may be submitted under supervisory or referring provider billing conventions or through a managed care plan, so the entity receiving payment and the entity performing the service should be confirmed.
- Higher per patient-month amounts for U0003 and 87798 can reflect legitimate test mix, panel composition, specimen volume during the COVID-19 period or state fee schedule differences rather than any billing irregularity.
- Several codes, including 87502, 87631, 87634 and G0483, price below the typical amount and at low percentiles, which is not consistent with a uniform upcoding pattern.
- Name and address similarity is not identity; confirm that the Baldwin Park, California entity paid by Missouri Medicaid is the same entity named on the revocation and state exclusion lists.
Sources, 11 public records
- 1. providers/NPPES: NPI 1962546176 MATIAS CLINICAL LABORATORY INC (organization), BALDWIN PARK, CA; taxonomy 291U00000X; Medicaid home state MO.
- 2. procedures billed, Medicaid: Code U0003 (Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r): $729,801 paid over 24 months, 18% of this provider's Medicaid dollars, $120 per patient-month, which ranks at the 88th percentile of all providers billing this code (typical $75).
- 3. procedures billed, Medicaid: Code 87798 (Detection test by nucleic acid for organism, amplified probe technique): $672,654 paid over 49 months, 17% of this provider's Medicaid dollars, $64 per patient-month, which ranks at the 75th percentile of all providers billing this code (typical $33).
- 4. procedures billed, Medicaid: Code 87502 (Detection test by nucleic acid for multiple types influenza virus): $348,859 paid over 49 months, 9% of this provider's Medicaid dollars, $55 per patient-month, which ranks at the 31th percentile of all providers billing this code (typical $71).
- 5. procedures billed, Medicaid: Code 87631 (Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets): $279,418 paid over 31 months, 7% of this provider's Medicaid dollars, $52 per patient-month, which ranks at the 33th percentile of all providers billing this code (typical $74).
- 6. procedures billed, Medicaid: Code 87634 (Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique): $258,473 paid over 48 months, 7% of this provider's Medicaid dollars, $41 per patient-month, which ranks at the 39th percentile of all providers billing this code (typical $48).
- 7. procedures billed, Medicaid: Code G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms): $206,715 paid over 25 months, 5% of this provider's Medicaid dollars, $118 per patient-month, which ranks at the 38th percentile of all providers billing this code (typical $146).
- 8. provider_risk: Evidence tier 1 (documented action, then payment); detectors D3; dollars at risk $3,846,471 (figure of the detector that set the tier, not a sum); reasons: Listed on the Medicare revocation list since August 31, 2018; Medicaid still paid claims in 44 later months, $3,846,471 in total.
- 9. Revocation_Extract: Revoked 2018-08-31 under 424.535(A)(4) False Or Misleading Information;424.535(A)(3) Felonies;424.535(A)(2) Provider Or Supplier Conduct (Exclusion); re-enrollment bar to 2034-11-22.
- 10. flags/D3 + T-MSIS spending: After the MEDICARE_REVOKED action of 2018-08-31 (424.535(A)(4) False Or Misleading Information;424.535(A)(3) Felonies;424.535(A)(2) Provider Or Supplier Conduct (Exclusion)), Medicaid paid $3,846,471 across 44 service months (2018-09 to 2022-04); $312,286 in the 12 months before.
- 11. flags/D3 + T-MSIS spending: After the STATE_EXCL_CA action of 2018-08-31 (CA Medi-Cal Suspended & Ineligible Provider List (July 2026)), Medicaid paid $3,846,471 across 44 service months (2018-09 to 2022-04); $312,286 in the 12 months before.